NSAIDs vs. Tylenol
This article was originally published in The Tan Sheet
Non-steroidal anti-inflammatory drugs are superior to acetaminophen for improving knee and hip pain in people with osteoarthritis, a review published in The Cochrane Database of Systematic Reviews finds. Tanveer Towheed, MD, Queen's University, Ontario, et al., analyzed 15 randomized controlled trials gleaned from a search of databases including MEDLINE and EMBASE; the studies dated from 1994 to July 2005 and lasted an average of six weeks. Researchers reviewed data on almost 6,000 people with osteoarthritis who took 4,000 mg of acetaminophen (McNeil's Tylenol) per day with those who took placebo or NSAID. Subjects who took NSAIDs reported lower levels of pain and increased movement; "in osteoarthritis subjects with moderate-to-severe levels of pain, NSAIDs appear to be more effective than acetaminophen," Towheed et al. state...
You may also be interested in...
Legal experts explain why India’s plans to abolish the Intellectual Property Appellate Board and shift its powers to courts may be problematic for stakeholders, including those pursuing infringement charges. The transition could mean a significant burden on courts both in terms of capability and capacity, and IPR cases will now conflate into all other pending commercial matters, some experts said, though others cheered the proposed change.
Ex-Novartis executive and co-founder of investment bank MM Dillon & Co shares insights around where healthcare unicorns can be found and some core criteria to build such firms.
In this week's podcast edition of Scrip's Five Must-Know Things, hear about Sanofi’s rebates, Moderna’s business prospects, US views on coronavirus vaccine comparisons, Piot talk about virus variants, and new results for Amgen's asthma drug.